Cas:1673-62-7 2-Methyl-1-vinyl-1H-benzimidazole manufacturer & supplier

We serve Chemical Name:2-Methyl-1-vinyl-1H-benzimidazole CAS:1673-62-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Methyl-1-vinyl-1H-benzimidazole

Chemical Name:2-Methyl-1-vinyl-1H-benzimidazole
CAS.NO:1673-62-7
Synonyms:2-Methyl-1-vinyl-1H-benzimidazole
Molecular Formula:C10H10N2
Molecular Weight:158.20000
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:17.82000
Exact Mass:158.08400
LogP:2.44520

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Methyl-1-vinyl-1H-benzimidazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methyl-1-vinyl-1H-benzimidazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-1-vinyl-1H-benzimidazole Use and application,2-Methyl-1-vinyl-1H-benzimidazole technical grade,usp/ep/jp grade.


Related News: The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 2-Methyl-1-vinyl-1H-benzimidazole manufacturer In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. 2-Methyl-1-vinyl-1H-benzimidazole supplier The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 2-Methyl-1-vinyl-1H-benzimidazole vendor The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. 2-Methyl-1-vinyl-1H-benzimidazole factory In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available.